Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers CofiledCriticalBristol Myers Co
Priority to FR6929682ApriorityCriticalpatent/FR2059986A1/en
Publication of FR2059986A1publicationCriticalpatent/FR2059986A1/en
Application grantedgrantedCritical
Publication of FR2059986B1publicationCriticalpatent/FR2059986B1/fr
C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Cephalosporin Compounds
(AREA)
Abstract
Bactericidal mono-N-acyl derivatives of amino acids These include compounds with the following formulae, and their salts, and where R' is an acylamino group.
FR6929682A1969-08-291969-08-29Bactericidel mono-n-acyl derivs of amino acids
GrantedFR2059986A1
(en)